ISSN: 2578-482X
Authors: Imane M*, Sanaa E, Hanan E, Tayeb K, Benkabbou A, Belkouchi A and Noureddine B
Objective: Digestive neuroendocrine tumors (NET) are a rare entity of neoplasia that represents 1% of digestive tumors, characterized by a heterogeneous biological, morphological, and clinical presentation. The aim of our study is to determine the particularities of the management of digestive NETs, as well as to evaluate the therapeutic modalities in comparison with the data of the existing literature, in order to improve the management of our patients. Materials and methods: This is a descriptive retrospective study including all patients operated for histologically proven gastrointestinal NET, at the level of the department of visceral surgery A (Ibn Sina Hospital, Rabat) between January 2012 and December 2016. Demographic, clinical, paraclinical, histological, and therapeutic data, as well as the follow-up was produced using farms return. Results: 10 patients were included in this study. Four patients had pancreatic tumors (40%), two had small bowel tumors (20%) and two had unknown primitives tumors (20%). Six patients were metastatic at the diagnosis (60%) in the liver. The surgery was for curative intent in eight patients (80%) and palliative in two patients (20%), three patients underwent surgery on the hepatic metastases (30%). Five patients were in stage IV of their disease (50%). One patient is alive with his disease (10%), two are alive without disease (20%) and three died from their disease (30%). Conclusion: Improving the knowledge of NETs and accessibility of standard diagnostic means explain the increase in diagnosed cases. An update knowledge and collaboration between surgeons, pathologists, radiologists and oncologists are required.
Keywords: Gastro-Intestinal and Pancreatic Neuro-Endocrine Tumors; Octreoscan; Surgery
